Covered recipient · General Payments record
RAVALI KONDAVEETI
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2021–2024
$1,271.95
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.74 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Pulmonx Corporation | $47.44 | 2 |
| Mallinckrodt Hospital Products Inc. | $35.19 | 1 |
| Actelion Pharmaceuticals US, Inc. | $30.93 | 1 |
| Merck Sharp & Dohme Corporation | $22.94 | 1 |
| Acerta Pharma LLC | $22.49 | 1 |
| Regeneron Healthcare Solutions, Inc. | $16.11 | 1 |
| GENZYME CORPORATION | $15.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $30.93 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078866537 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.49 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105492055 | CMS |
| GENZYME CORPORATION | $15.64 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139570958 | CMS |
| Mallinckrodt Hospital Products Inc. | $35.19 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145094736 | CMS |
| Merck Sharp & Dohme LLC | $22.94 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141598082 | CMS |
| Pulmonx Corporation | $20.11 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087848587 | CMS |
| Pulmonx Corporation | $27.33 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087848589 | CMS |
| Regeneron Healthcare Solutions, Inc. | $16.11 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114090985 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.